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Polychlorinated biphenyls (PCBs) are persistent organic pollutants in insulating oil of a large number of
transformers. A rapid and economical analytical method to detect PCB contamination is still required. To
address this issue, we propose here the ﬁrst microﬂuidic screening method for PCB contamination in
insulating oil. The insulating oil was pretreated using a multilayer capillary column and a microﬂuidic
liquid–liquid partitioning. PCBs in the pretreated oil were measured using a microﬂuidic kinetic exclusion
assay. In order to detect PCBs with high sensitivity, conditions of the microﬂuidic kinetic exclusion assay
were optimized. Measurements were rapidly completed (within 43 min). The measurement range was
estimated to be 0.26–3.3 mg/kg deﬁned as the relative absorbance from 20% to 80%. The screening per-
formance (false positive and false negative rates) was tested on ﬁfty real oil samples; results about these
tests were discussed in detail, especially suitable cutoff by comparing with the data analyzed using high-
resolution-gas-chromatography/high-resolution-mass-spectrometry. Finally, the screening performance
was conﬁrmed using our proposed stochastic screening model. A cutoff of 0.3 to judge as positive is suit-
able considering the risk of the PCB release into the environment.
 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Since polychlorinated biphenyls (PCBs) have a high thermal sta-
bility, chemical resistance, and electrical insulating properties,
they have been widely used in various applications, such as dielec-
tric ﬂuids in transformers and capacitors, and heat transfer ﬂuids
[1]. Complex mixtures of PCBs (Aroclor, Kanechlor, etc.) were com-
mercially produced from 1929 to the early 1970s. Concern about
their environmental persistence began in the late 1960s when
Swedish researchers reported the presence of PCBs in environmen-
tal samples [2]. The ﬁrst human poisoning due to their toxicity
occurred in Western Japan in 1968, and a second similar poisoning
occurred in Taiwan in 1979 [3]. The toxicity of PCBs was increas-
ingly recognized in the wake of these incidents. The production
and use of PCBs were therefore prohibited in the USA and Japan
in the 1970s. However, PCB contamination has been detected in
transformers produced after these prohibition laws were passed.
Because of the concern of possible PCB contamination in a large
number of transformers, PCB contamination in every transformershould be tested. However, typical analytical methods using gas
chromatography (GC) coupled with either mass spectrometry
(MS) or electron capture detection [4–7] are time consuming and
expensive. In the ﬁeld of medicine, screening with immunoassays
is often used, because of its cost- and time-efﬁciency. Using a sim-
ilar approach for PCBs may lead to the development of a rapid and
economical test method.
We have previously reported immunoassays that employ spe-
ciﬁc antibodies for PCBs to measure PCBs in insulating oils [8,9].
The previous method needed 3 h for each oil sample. In order to
achieve more rapid, simple, and low-cost procedures, the pretreat-
ment method has been improved by using a micro total analysis
system [10,11]. Micro total analysis systems are recognized as
powerful tools for high-speed, functional, and compact instrumen-
tation used for analytical, synthetic, and biological chemistries
[12–14]. Previous methods include batch processes that require
an evaporator for concentrating PCBs and a centrifugation device
for phase separation. The improved pretreatment enables a contin-
uous process that replaces the evaporator and centrifuge steps by
using a multilayer capillary column, allowing for less-diluted sam-
ples, interfaced with microﬂuidic concentrated liquid–liquid parti-
tioning. The multilayer column was miniaturized using a capillary,
which reduced the amount of reagent to less than 1/12 of that
required in previous columns. Pretreatment was completed within
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can be applied to small molecules with high sensitivity has been
reported [15,16]. A combination of microﬂuidic pretreatment and
kinetic exclusion assay results in signiﬁcantly improved screening
procedures.
In this study, we report the screening of PCBs in transformer oil
using a multilayer capillary column, microﬂuidic liquid–liquid par-
titioning, and microﬂuidic kinetic exclusion assay. Several mea-
surement parameters for the microﬂuidic kinetic exclusion assay
were examined to achieve high sensitivity. Sensitivity was evalu-
ated from a standard curve generated using microﬂuidically pre-
treated oil samples. Fifty real used transformer oil samples were
examined by high-resolution-GC/high-resolution-MS (HRGC/
HRMS); these were also tested using the developed screening
method. Screening performance was evaluated by comparing the
false positive and false negative rates of the assays. The evaluation
of the screening performance was stochastically conﬁrmed.2. Materials and methods
2.1. Screening PCBs in oil
Fig. 1 shows the design for the screening of the PCBs in oil,
which makes use of a multilayer silica-gel column, microﬂuidic
liquid–liquid partitioning device, and microﬂuidic kinetic exclu-
sion assay device. The interfering substances in the PCB-contami-
nated oil are sulfonated and separated in the column. Any
remaining interfering substances were cleaned up by microﬂuidic
liquid–liquid partitioning, which permits the extraction of PCBs
in the eluate into dimethyl sulfoxide conﬁned in the microrecesses.
After the antigen–antibody reaction occurred, PCBs were measured
by microﬂuidic kinetic exclusion assay. Free antibodies labeled
with gold nanoparticles accumulated onto the surface of the anti-
gen-immobilized beads. The absorbance of gold nanoparticles on
the surface of the beads was measured with a light-emitting diode
(LED) and photodiode.
2.2. Reagents
Commercial mixtures of PCBs (Kanechlor 300, 400, 500, and
600; 1:1:1:1 mixture) were purchased from GL Sciences Inc.
(Tokyo, Japan). PCB-free insulating oil for electric transformers
was purchased from Matsumura Oil Co., Ltd. (Barrel Trans M;
Osaka, Japan). Anhydrous sodium sulfate, oleum-impregnated sil-
ica gel, and aminopropyl silica gel were purchased from Sumika
Chemical Analysis Service, Ltd. (Osaka, Japan). DMSO (Catalog No.
346-03615) was purchased from Dojindo Laboratories (Kumamoto,
Japan). Acetone and hexane were purchased from Wako Pure
Chemical Industries, Ltd. (Osaka, Japan). PBS (consisting of
137 mM sodium chloride, 3 mM potassium chloride, 20 mMFig. 1. Schematic view of the screening of PCBs in oil using multilayer silica-gel capillary
exclusion assay.disodium hydrogen phosphate, 1.5 mM potassium dihydrogen
phosphate, and 1.5 mM sodium azide; pH 7.4) was prepared in-
house. A blocking reagent, N101, was purchased from NOF Corpo-
ration (Tokyo, Japan). BSA (bovine serum albumin) was purchased
from Sigma Aldrich (Tokyo, Japan). A monoclonal anti-PCB anti-
body (K2A) was purchased from Kyoto Electrics Manufacturing
Co., Ltd. (Kyoto, Japan). The PCB contamination in used insulating
oil is of commercial PCB mixtures origins (Kanechlor in Japan,
and Aroclor in USA, etc.). Since K2A showed equal response
towards the Kanechlor (KC-300, 400, 500, and 600) [17], K2A can
be applied to samples composed of various PCB congeners.
2.3. Oil samples
Commercial mixtures of PCBs (Kanechlor 300, 400, 500, and
600; 1:1:1:1 mixture) were added to pure insulating oil used in
electric transformers to prepare the standard oil samples. Real
PCB-contaminated oil samples for the evaluation of the screening
performance were obtained from ﬁfty used transformers. The main
component of the real oil samples was mineral oil.
2.4. Pretreatment of insulating oil
Oil samples were pretreated with a microﬂuidic device for
liquid–liquid partitioning interfaced with a multilayer capillary
column [11]. A 190 mm long 1/1600  1/800 Teﬂon tube was used
for the multilayer capillary column. The multilayer capillary col-
umn consisted of 64 mg of anhydrous sodium sulfate, 170 mg of
oleum-impregnated silica-gel, 64 mg of anhydrous sodium sulfate,
and 50 mg of aminopropyl silica-gel, from top to bottom. Quartz
wool was packed in the lowest layer of the capillary to prevent
leakage of the ﬁllers. A 50 lL aliquot of oil sample was injected
at a distance of 10 mm from the ﬁllers with a micropipette to pre-
vent broadening of the oil by capillary force in the ﬁllers; this was
followed by elution with hexane at a 50 lL/min ﬂow rate, which
was lower than that reported in our previous study (the ﬂow rate
was 100 lL/min) [11]. A portion of interfering substances was sep-
arated in the column. The remaining interfering substances were
separated using a microﬂuidic liquid–liquid partitioning. A photol-
ithographic wet-etching method was used to fabricate microchan-
nels on a glass substrate, as described in our previous study [11].
The fabricated microchannels were thermally bonded to another
substrate with 0.5 mm inlet and outlet holes. Fig. 2 shows a photo-
graph of the microﬂuidic device and an illustration of the micro-
channel structure, which consisted of a main microchannel (L
610 mm W 260 lm  D 50 lm) and 1212 rectangular microre-
cesses (L 520 lm W 520 lm  D 50 lm). The volume of the main
microchannel was estimated to be 7.3 lL. Considering the rounded
structures of the microrecesses, which result from the fabrication
procedure carried out with a wet-etching method, the volume ofcolumn separation, microﬂuidic liquid–liquid partitioning, and microﬂuidic kinetic
Fig. 2. Photograph of the microﬂuidic liquid–liquid partitioning device, and
illustration of the microchannel structure.
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total volume of the microrecesses of approximately 14.8 lL. DMSO
as extractant of the PCBs can be spontaneously ﬁlled in the mic-
rorecesses by ﬂowing DMSO into the vacant microchannels. The
ﬂow rate was changed to 10 lL/min upon the introduction of the
eluate into the microﬂuidic device from the multilayer capillary
column; PCBs in the eluate were extracted into DMSO conﬁned
in the microrecesses for 15 min. After airﬂow to expunge the eluate
was applied, the DMSO was expelled by ﬂowing 1 mL of phos-
phate-buffered saline (PBS) at a 500 lL/min ﬂow rate. Pretreat-
ment was completed within 21 min. In the general pretreatment,
repeated DMSO partitioning is performed to obtain high recovery
rate of PCBs. In our pretreatment, the recovery rate is low because
of single DMSO partitioning. Since the application of our developed
system to the rapid screening is assumed, we put a priority on the
short process time.2.5. Preparation of the solid phase
Antigen immobilization to 1 mL of NHS-activated SepharoseTM
4 Fast Flow (Amersham Biosciences) was placed in a centrifuge
tube; the added isopropanol was allowed to drain. The beads were
then suspended in 1 mL of cold 1 mM HCl, and allowed to drain.
This process was repeated ten times with 1 mM HCl and then
repeated ten times with cold PBS prepared without sodium azide.
After the ﬁnal PBS wash, the beads were suspended in 0.9 mL of
PBS, and 0.1 mL of 1 mg/mL coating protein/PBS solution was
added. As described in previous studies [15,16], the coating protein
was a dichlorophenol BSA conjugate. DMSO supplemented with
10 lg/mL of succinimidyl 6-(3,4-dichlorophenoxy)hexanoate (des-
ignated S1) synthesized from 3,4-dichlorophenol and a solution
containing borate buffer (100 nM, pH 9.8) supplemented with
1.7 mg/mL of BSA were mixed in darkness overnight at 4 C. The
beads were rotated at room temperature for 2 h; 0.1 mL of
100 mg/mL BSA/PBS solution was then added, and the beads
rotated at room temperature for 2 h. The beads were suspended
in 30 mL PBS and kept refrigerated for several weeks.2.6. Preparation of the gold nanoparticle-labeled antibodies
Monodispersed colloidal gold nanoparticles (20 nm in size)
were prepared using standard procedures. In a 500 mL round-bot-
tomed ﬂask equipped with a reﬂux condenser, 5 mL of 1% HAuCl4
was brought to a vigorous boil with stirring. Rapid addition of
5 mL of 1% sodium citrate (w/v) solution to the vortex of the solu-
tion caused a color change, from pale yellow to blue, and then to
red-violet; boiling was continued for 10 min. The heating mantle
was then turned off, and the solution was allowed to cool to
20 C. To prepare the gold nanoparticle-labeled antibodies,
0.2 mL of antibody (1.5 mg/mL) was added to 200 mL of the gold
nanoparticle solution adjusted to pH 9.15. This was followed by
periodic gentle mixing, after which the solution sat undisturbed
at room temperature for 2 min to allow absorption of the antibody
onto the gold nanoparticle surface; it was then saturated with the
addition of BSA (1% concentration). The conjugate was then centri-
fuged at 9000 rpm for 25 min. Finally, the sediment (15 mL) was
collected and stored at 4 C. Prepared gold nanoparticles did not
show any nonspeciﬁc adsorption toward the solid phase or
microchannels.
2.7. Microﬂuidic kinetic exclusion assay
The microﬂuidic device for the kinetic exclusion assay used in
this work is similar to that described in our previous studies
(Fig. 3) [15,16,18]. The microﬂuidic device consisted of a main
microchannel employed to introduce the sample solution and the
buffer, along with a sub microchannel to manipulate the beads.
The bead-packing area, which was aligned with the LED and pho-
todiode, had a width of 1 mm, length of 2 mm, and depth of
275 lm. In order to pack the beads having an average diameter
of 90 lm, a pillar structure with barriers 100 lm wide at intervals
of 50 lm was fabricated. The sample solution was prepared by
mixing a 950-lL of the pretreated solution with a detection anti-
body labeled with gold nanoparticles, DMSO, PBS over 15 min
(ﬁnal volume: 1 mL, ﬁnal DMSO concentration: 2%, and ﬁnal con-
centration of BSA: 0.1%). Microchannel walls were coated with
blocking reagents by ﬂowing 2% N101-PBS solution over 30 min.
Antigen-immobilizing beads were packed in the pillar area by
ﬂowing a 40 mg/mL bead solution from the sub microchannel at
a 700 lL/min ﬂow rate. The quantity of transmitted light (I0)
through beads before the introduction of the sample was measured
using an LED (k = 520 nm) and a photodiode. The sample solution
was then ﬂowed through the beads to allow binding of the free
antibodies to the antigen-immobilizing beads. Unbound free anti-
bodies were washed with 1 mL of PBS containing 1 mg/mL BSA.
Finally, the quantity of transmitted light (I) through the beads
binding antibodies was measured. Absorbance (A) was calculated
using I and I0 (A = log10 (I/I0)). The relative absorbance was
deﬁned as the ratio between the sample absorbance and zero-anti-
gen absorbance. The microﬂuidic kinetic exclusion assay process,
from the antigen–antibody reaction to absorbance measurement,
was completed within 22 min.
2.8. High-resolution gas chromatographyHigh-resolution mass
spectrometry (HRGC/HRMS)
HRGC/HRMSworkswas carried out at Sumika Chemical Analysis
Service using the Japanese ofﬁcial method [19,20]. Brieﬂy, a 0.5 g oil
sample is spiked with an internal standard (a mixture of equal
weights of 4-chloro [13C12]biphenyl, 2,40-dichloro[13C12]biphenyl,
2,4,40-trichloro[13C12]biphenyl, 2,20,5,50-tetrachloro[13C12]biphenyl,
2,20,4,5,50-pentachloro[13C12]biphenyl, 2,30,4,40,5-pentachloro-[13C12]
biphenyl, 2,20,3,4,40,50-hexachloro[13C12]biphenyl, 2,20,4,40,5,50-hexa-
chloro[13C12]biphenyl, 2,20,3,4,40,5,50-heptachloro[13C12]biphenyl,
Fig. 3. Illustration of the microﬂuidic device for the kinetic exclusion assay and microchannel structure.
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nonachloro[13C12]biphenyl, 2,20,3,30,4,40,5,50,6,60-decachloro[13C12]-
biphenyl, and 2 mL of n-hexane is added. Next, 25 mL of DMSO is
added, the mixture is shaken for 15 min and then let stand for
15 min, and the DMSO phase is decanted. The DMSO addition is
repeated four times yielding 100 mL of DMSO total. The DMSO is
washedwith 40 mL of n-hexane, and the hexane phase is discarded.
A total of 100 mL of deionized water is added to the DMSO. Next,
75 mL of n-hexane is added, shaken for 15 min, and let stand for
15 min. The hexane phase is retained, and the process is repeated
three times for a total of 225 mL of hexane. The hexane phase is
washed with 10 mL of 2 M KOH; the KOH phase is discarded.
Residual water in the hexane phase is removed by pouring throughFig. 4. Optimization of microﬂuidic kinetic exclusion assay showing: (A) the relationship
150 lL/min ﬂow rate; (B) the relationship between the reciprocal of the ﬂow rate and
relationship between the ﬂow volume of the sample and the absorbance at 150 pM of ant
with the respective standard deviations.a funnel packed with sodium sulfate. The hexane phase is evapo-
rated to 0.5 mL and applied to a silica gel column. The column is
eluted with 120 mL of hexane, which then concentrated by
evaporation to 50 lL, spiked with mass standards (equal weights
of 3,4,40-trichloro[13C12]biphenyl, 2,20,3,50,6-pentachloro[13C12]-
biphenyl, and 2,20,3,30,5,50,6,60-octachloro[13C12]biphenyl) and
measured by GC–MS (GC: HP-6890N (Agilent); column: HT-8
(SGE) 50 m  0.22 mm (i.d.)  0.25 lm; temperature: 130 C
(1 min)? (20 C/min)? 220 C (0 min)? (5 C/min)? 320 C
(15 min); injector: 280 C; injection: splitless 1 lL) and Autospec
ULTIMA Micromass (ionization: EI (electron impact) 40 V 500 lA;
acceleration voltage: 8 kV; interface: 325 C; ion source: 335 C;
resolution: M/DM > 10,000).between the antibody concentration and absorbance at a 750 lL ﬂow volume and
the relative absorbance at 150 pM of antibody and a 750 lL ﬂow volume; (C) the
ibody and a 150 lL/min ﬂow rate. All data points represent triplicate determinations
Fig. 5. Standard curve for PCBs in oil found by microﬂuidic kinetic exclusion assay
after the microﬂuidic pretreatment. Solid circles represent experimental results;
solid line marks represent the ﬁtting curve. All data points represent triplicate
determinations with the respective standard deviations.
Fig. 6. Correlation between HRGC/HRMS and the microﬂuidic screening test. The
solid line represents the best-ﬁt line to the data.
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3.1. Microﬂuidic kinetic exclusion assay for PCBs
The kinetic exclusion assay must satisfy several conditions to
achieve the theoretical level of detection: (i) prevent an equilib-
rium shift between the antibody and analyte due to binding of
the free antibody to the antigen-immobilized beads, (ii) mutual
exclusion of binding of the immobilized and corresponding soluble
analytes, and (iii) sufﬁciently tight and rapid binding of the anti-
body to the immobilized analyte to permit accumulative capture,
leading to a quantitative instrument response with an acceptable
signal-to-noise ratio [21]. Although the detection limit of 31 ng/
kg has been achieved in the aqueous samples [18], the achieve-
ment of the theoretical detection limit in our system is difﬁcult
because of the restriction of the sample volume. Therefore, we
studied three parameters, namely, antibody concentration, ﬂow
rate, and ﬂow volume, that would enable the highly sensitive
detection of PCBs. Firstly, the optimal antibody concentration
was examined. After the bead packing was completed, 750 lL of
sample solution containing 50–250 pM of anti-PCBs antibody was
ﬂowed at 150 lL/min. The resulting absorbance varied linearly as
a function of the antibody concentration over a range of 50–
150 pM (Fig. 4A). Secondly, 750 lL of sample solution containing
150 pM of antibody was ﬂowed at 50–300 lL/min. The resulting
relative absorbance decreased as the ﬂow rate increased until a
constant value was reached at a higher ﬂow rate (in excess of
150 lL/min) (Fig. 4B). Finally, 100–1000 lL of sample solution con-
taining 150 pM of antibody was ﬂowed at 150 lL/min. A linear
relation between absorbance and ﬂow volume was found over a
range of 100–750 lL (Fig. 4C). Therefore, the optimal values for
each assay were as follows: antibody concentration of 150 pM,
ﬂow rate of 150 lL/min, and ﬂow volume of 750 lL.
3.2. Standard curve for PCBs
Once the optimal conditions for the microﬂuidic kinetic exclu-
sion assay were determined, we obtained the standard concentra-
tion dependence curves of the microﬂuidic kinetic exclusion assay
using microﬂuidically pretreated oil samples on the multilayer
capillary column and the microﬂuidic liquid–liquid partitioning
device. Fig. 5 shows the standard curve (with error bars) from three
replications of the experiment. The solid line in Fig. 5 corresponds
to curve ﬁts for the experimental results obtained using a four-
parameter logistic equation [10]. The measurement range was esti-
mated to be 0.26–3.3 mg/kg, and deﬁned as the relative absor-
bance from 20% to 80%. The Japanese regulation criterion of
0.5 mg/kg [22] was therefore met. The half-maximal inhibitory
concentration was estimated to be 0.94 mg/kg. The procedures,
including pretreatment and immunoassay, were completed within
43 min, while the previous method required 3 h [8].
3.3. Correlation between the microﬂuidic screening test and HRGC/
HRMS
We prepared the standard samples by mixing equal amounts of
Kanechlor 300, 400, 500, and 600. However, the composition ratio
of each Kanechlor depends on the real oil sample used. Further-
more, we employed pure insulating oil for the preparation of the
standard samples, whereas various insulating oils are present in
real oil samples. The components of the mineral oils are different
from lot to lot. These factors may inﬂuence the clean-up and recov-
ery rates of PCBs because of the different partitioning coefﬁcient.
Therefore, performance should be quantitatively estimated when
standard curves from the standard oil samples are applied to the
measurement of real oil samples. We evaluated the accuracy ofthe microﬂuidic screening test using a multilayer capillary column,
microﬂuidic liquid–liquid partitioning device, and microﬂuidic
kinetic exclusion assay device. Fifty real oil samples were mea-
sured with the microﬂuidic screening test and HRGC/HRMS (the
latter used as reference). A satisfactory correlation between mea-
sured values with HRGC/HRMS and microﬂuidic screening test
(Fig. 6) was found, with the slop, intercept, and correlation coefﬁ-
cient being 0.81, 0.01, and 0.81, respectively. However, the values
measured by the microﬂuidic screening test were found to be
systematically lower than those obtained with HRGC/HRMS. The
18 A. Aota et al. / Analytical Chemistry Research 3 (2015) 13–19recovery rate of PCBs from the real oil samples may be decreased
compared with that from the standard samples prepared using
pure insulating oil.
3.4. Screening performance
In order to evaluate the screening performance, the false posi-
tive and false negative rates (FP and FN) were calculated. The val-
ues measured using the microﬂuidic screening test were
separated into positives and negatives for a series of cutoff values,
and were then further separated into true positives, true negatives,
false positives, and false negatives by comparison to those
obtained with HRGC/HRMS measurements of each sample. FP
was computed by dividing the false positive count by the sum of
the true negative and false positive count; FN was computed by
dividing the false negative count by the sum of the true positive
and false negative count. The calculated FP and FN were plotted
against the cutoff (Fig. 7); the calculated FP and FN for the sample
population were also checked against the previously proposed sto-
chastic model [23]. The solid and dashed lines in Fig. 7 correspond
to the simulated FP and FN using the slope, intercept, and standard
deviation of the correlation between the HRGC/HRMS and micro-
ﬂuidic screening test. Since the calculated values agreed with the
simulated values, the evaluation of the screening performance
was stochastically conﬁrmed.
There is an intuitive appeal to the cutoff corresponding to the
intersection of the FP and FN curves (Fig. 7), which corresponds
to a popular metric, namely, the maximum Youden Index (J)
[24,25]. The cutoff based on the maximum J calculated from the
simulated results was approximately 0.4. FP and FN were calcu-
lated to be 0.30 and 0.14, respectively, when a cutoff of 0.4 was
assigned. When false positive and false negative errors areFig. 7. Screening result of the measurement and ﬁtted functions. Solid red circles
and solid blue triangles indicate the false negative (FN) and false positive (FP) rates,
respectively. The solid and the dashed lines indicate the simulated results for FN
and FP, respectively.weighted identically, the maximum J gives the optimal cutoff.
However, a lower FN is more appropriate than the one based on
the maximum J, because a false negative allows PCB-contaminated
oil to be disposed of as if it were uncontaminated. When the cutoff
was set 0.3, FP and FN were calculated to be 0.52 and 0.04, respec-
tively. A cutoff of 0.3 is more suitable, considering the risk of the
PCB release into the environment, even if half of the negative sam-
ples can be judged as positive samples.
4. Conclusions
We have developed and demonstrated a microﬂuidic screening
of PCBs in oil by utilizing a multilayer capillary column separation,
a microﬂuidic liquid–liquid partitioning, and a microﬂuidic kinetic
exclusion assay. Each measurement by the developed method was
rapidly completed within 43 min while that by the conventional
method need 2 days. The measurement range was estimated to
be 0.26–3.3 mg/kg. The correlation of measured values between
the microﬂuidic screening test and HRGC/HRMS was good. When
the cutoff was set as 0.3, the false negative rate was calculated to
be 0.04. The data presented in this study showed that our devel-
oped test method represents a signiﬁcant improvement of previ-
ously reported methods for a cost-effective detection of PCB
contamination in oils.
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